Stockreport

ALX Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]

ALX Oncology Holdings Inc.  (ALXO) 
PDF clinical benefit in patients with HER2-positive gastric cancer in an oral presentation at 2025 ASCO GI – Presented Phase 1b/2 data demonstrating evorpacept in combinat [Read more]